Elsevier,
Clinician's Guide to Sexuality and Autism
A Guide to Sex Education for Individuals with Autism Spectrum Disorders
2024, Pages 9-16
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by outlining how to use the book to provide effective teaching in sexuality education with an emphasis on individualization for specific learners.
This content aligns with Goal 3: Good Health and Wellbeing by presenting the current evidence for HIV/AIDS prevention.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reduced Inequalities by providing information about access to evidence-based treatment and prevention interventions as well as addressing the underlying social, political and economic issues, such as poverty, lack of access to healthcare, and stigma and discrimination that contribute to the high burden of HIV in the region
With a pressing climate emergency and increasing interconnectedness, the need for action on health at a global level is greater than ever. Achieving Universal Health Coverage with a strong base in primary healthcare is essential. This must be accompanied by policies to address the socioeconomic and environmental determinants of ill health, supporting SDG3.
This content aligns with Goal 3: Good Health proving that viral hepatitis is increasing as a global challenge, in contrast to other major infectious causes of death (e.g. tuberculosis (TB), HIV, and malaria).
This article ties with climate action and reproductive medicine, as it is a reflexion on healthcare carbon footprint especially the IVF laboratories.
This article supports SDG 3 by assessing the changes in mortality rate and years of life lost associated with dementia attributable to high BMI in China. The findings suggest a rapid increase in dementia burden attributable to high BMI.
WHO recommends dolutegravir as the preferred anchor drug for first-line and second-line HIV treatment, and is being rolled out globally. This study shows that dolutegravir is safe but clinicians should nonetheless be aware of the risk of psychiatric manifestations in children and adolescents taking the drug.
This Article supports SDG 3 by showing, through a modelling analysis, that community tenofovir, lamivudine, and dolutegravir (TLD) is likely to reduce HIV incidence and be cost-effective, thus leading to population health benefits.
This Article supports SDG 3 by showing that interventions and strategies to reduce mortality from HIV-related CNS infection in public hospitals within routine care services can substantially reduce all-cause 2-week mortality among people living with HIV presenting to public hospitals with suspected HIV-related CNS infection.
